Serum lipid profile and metabolic syndrome occurrence among obese rural women from Lublin Region [Eastern Poland]

• Autorzy: Filip R.S. , Panasiuk L. , Haratym-Maj A. , Radzki R.P. , Bienko M. , Puzio I.
• Języki publikacji: EN

Abstrakty

EN

Obesity is a multivariate syndrome which can negatively affect whole body functioning. It is most common in highly developed countries, and in recent years a progressive increase in obesity occurrence is noticeable. The aim of the study was to assess serum lipid profile and metabolic syndrome occurrence among obese rural women from Lublin Region in Eastern Poland. The study was conducted in the Institute of Agricultural Medicine in Lublin (IAM). All subjects had a negative history of diseases and treatment that could affect serum lipid profile or glucose measurements. The inclusion criterion for the study group was overweight and obesity, defined as a body mass index above 25 (BMI>25) and living in a rural area. 44 women participated in the study. There were no women fulfilling the criteria or who had a history of incorrect fasting glucose (IFG) or incorrect glucose tolerance (IGT). In contrast, the prevalence of arterial hypertension (or treatment) was high - 53%. 22.7% women had normal serum TC values. The proportion of those with hyper-LDL-C was 38.6% and with hyper-TG - 18.2%. 20.5% of studied women had incorrect serum HDL-C levels, and in 15.9% hypo- HDL-C was accompanied by high serum TC levels. Analysis of correlation showed that serum TC was positively correlated with both LDL- and HDL-C. 55% of the studied obese or overweight women had at least 2 additional components of the metabolic syndrome.

Słowa kluczowe

EN

human disease; Poland; total cholesterol; rural woman; metabolic syndrome; woman; rural population; cholesterol; obesity; serum lipid profile; Lublin region

• Wydawca: -
• Czasopismo: Annals of Agricultural and Environmental Medicine
• Rocznik: 2006
• Tom: 13
• Numer: 1
• Opis fizyczny: p.77-80,ref.

Twórcy

autor

Filip R.S.

• Institute of Agricultural Medicine, Jaczewskiego 2, 20-950 Lublin, Poland

autor

Panasiuk L.

autor

Haratym-Maj A.

autor

Radzki R.P.

autor

Bienko M.

autor

Puzio I.

Bibliografia

• 1. Bhuripanyo K, Tatsanavivat P, Matrakool B, Muktabhant B, Bhuripanyo P, Harnthaveesompol S: A prevalence survey of lipids abnormalities of rural area in Amphoe Phon, Khon Kaen. J Med Assoc Thai 1993,76(2), 101-108.
• 2. Broda G, Szczesniewska D, Rywik S: The prevalence of the metabolic syndrome in the Warsaw adult population. Med Metabol 2003, 8, 25-34.
• 3. Burtis CA, Ashwood ER: Tietz Textbook of Clinical Chemistry , 3rd ed. Philadelphia, PA, WB Saunders, 1999, 776-777, 1815.
• 4. Ekoe JM: Recent trends in prevalence of and incidence of diabetes mellitus syndrome in the world. Diabetes Rech Clin Pract 1986,1, 249-264.
• 5. Ernst ND, Sempos CT, Briefel RR, Clark MB: Consistency between US dietary fat intake and serum total cholesterol concentrations: the national health and nutrition examination surveys. Am J Clin Nutr 1997, 66, 965-972.
• 6. Frederich RC, Lollmann B, Hamann A, Napolitano-Rosen A, Kahn BB, Lowell BB, Flier JS: Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity. J Clin Invest 1995, 96(3), 1658-1663.
• 7. Grabauskas V, Miseviciene I, Klumbiene J, Petkeviciene J, Milasauskiene Z, Plieskiene A, Margeviciene L: Prevalence of dyslipi- demias among Lithuanian rural population (CINDI program). Medicina (Kaunas) 2003, 39(12), 1215-1222.
• 8.Kromhout D: Diet and cardiovascular diseases. J Nutrition Health Aging 2001, 5, 144-149.
• 9. Kuulasmaa K, Tunstall-Pedoe H, Dobson A: Estimation of contribution of changes in classic risk factors to trends in coronaryevent rates across the WHO MONICA Project populations. Lancet 2000, 355, 675-687.
• 10. Liese AD, Mayer-Davis EJ, Haffner SM: Development of the multiple metabolic syndrome: an epidemiologic perspective. Epidemiol Rev 1998,20, 157-172.
• 11. Masuzaki H, Ogawa Y, Isse N, Satoh N, Okazaki T, Shigemoto M, Mori K, Tamura N, Hosoda K, Yoshimasa Y, Jingami H, Kawada T, Nakao K: Human obese gene expression. Adipocyte-specific expression and regional differences in the adipose tissue. Diabetes 1995, 44(7), 855-858.
• 12. Njelekela MA, Negishi H, Nara Y, Sato T, Tomohiro M, Kuga S, Noguchi T, Kanda T, Yamori M, Mashalla Y, Liu LJ, Ikeda K, Mtabaji J, Yamori Y: Obesity and lipid profiles in middle aged men and women in Tanzania. East Afr Med J 2002, 79(2), 58-64.
• 13. Rahman Al-Nuaim A: Effect of overweight and obesity on glucose intolerance and dyslipidaemia in Saudi Arabia, epidemiological study. Diabetes Res Clin Pract 1997, 36, 181-191.
• 14. Rywik S, Piotrowski W, Pająk A, Broda G, Rywik T: Relationship between metabolic disturbances and overweight or obesity in random sample of Polish population aged 20-74 years- The POLMONICA bis project. Med Metabol 2003, 8, 16-24.
• 15. Pajak A, Broda G, Sznajd J, Rywik S, Jamska B, Chodkowska E, Czarnecka H, Bednarska M, Rostworowski W, Kurjata P et al.: Plasma lipid and lipoprotein levels among rural and urban populations in Poland in relation to risk factors of coronary disease. Przegl Lek 1990, 47, 454- 458 (in Polish).
• 16. Schaefer EJ: Lipoproteins, nutrition, and heart disease. Am J Clin Nutr 2002, 75, 191-212.
• 17.Siedel J, Hagele E, Ziegenhorn J, Wahlenfeld W: Monotest cholesteol. Clin Chem 1983, 29, 1075-1078.
• 18. Southwell A, Eckland D: Managing the burden of type 2 diabetes: an international survey of physicians. Prat Diab Intern 1997, 14, 201- 206.
• 19. Szklo M, Chambless LE, Folsom AR, Gotto A Jr, Nieto FJ, Patsch W, Shimakawa T, Sorlie P, Wijnberg L: Trends in plasma cholesterol levels in the atherosclerosis risk in communities (ARIC) study. Prev Med 2000, 30(3), 252-259.
• 20. Wahlefeld AW: Triglicerydes determination after enzymatic hydrolysis. In: Bergmeyer HU (Ed.): Methods of Enzymatic Analysis. New York, London, 1974, 1831.
• 21. World Health Organisation: Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, World Health Organization 1999 (WHO/NCD/NCS/99.2).
• 22. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372(6505), 425-432.